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Predictors of morbidity and mortality with
endovascular and open thoracic aneurysm repair
Ellen D. Dillavou, MD, and Michel S. Makaroun, MD, Pittsburgh, Pa
Background: Open and endovascular thoracic aneurysm repairs are associated with significant complications including
paraplegia, stroke, vascular insufficiency, and death. Predictors of adverse outcomes are not well-defined in this patient
population.
Methods: The database of the GORE TAG (W.L. Gore, Flagstaff, Ariz) Pivotal Trial comparing the TAG endograft to
open repair was interrogated. Univariate (UVA) and multivariate analyses (MVA) of demographic, clinical, anatomic,
and procedural variables were conducted to discover possible predictors of serious adverse events for the whole group and
for the TAG and open cohort groups separately. Early adverse outcomes occurred within 30 days or the initial
hospitalization. P value of < .05 was significant.
Results: A total of 140 TAG and 94 open descending thoracic aneurysm (DTA) patients were analyzed, consisting of 128
men and 106 women. Perioperative deaths were 9/94 for open surgery and 3/140 for TAG patients, with 10/12 (7
open, 3 TAG) deaths occurring in men. Two female deaths were both after open surgery. Multivariate analysis showed
predictors of death for all patients were symptomatic aneurysms and male gender. Analysis of a combined morbidity/
mortality endpoint (stroke/paralysis/MI/death) showed elevated creatinine predicted these events for the whole group.
Open surgery (P < .001) and increasing aneurysm diameter (P < .001) predicted an increased likelihood of any major
adverse event. Open surgery was significantly associated with an increased risk of paraplegia (P  .002). Vascular
complications weremore frequent in the TAG (19%) than in openDTA patients (9%) (P .038). Female gender (P .01)
predicted vascular complications within the endovascular group. For all analyses, long procedure times were correlated
with adverse events. Women were noted to have longer procedure times for both TAG and open repairs.
Conclusion: Elevated creatinine levels and symptomatic aneurysms predict morbidity and mortality, respectively, regard-
less of repair type. Male gender predicted death after open surgery, and since most deaths (9 of 12) were in this group,
male gender predicted death overall, despite women’s more difficult endovascular TAA repairs as evidenced by longer
procedure times and higher vascular complication rates. All major adverse events and paraplegia were more common for
open surgery patients. ( J Vasc Surg 2008;48:1114-20.)With an aging population and new treatment options
available, repairs of descending thoracic aneurysms (DTA)
are likely to become more common.1-4 Both open and
endovascular repair of descending thoracic aneurysm have
been shown to have multiple and serious complications.5-7
There are few predictors of these adverse events, for open or
thoracic endovascular aneurysm repair (TEVAR), making
patient education and selection difficult.
Until recently, the Gore TAG stent graft (W.L. Gore,
Flagstaff, Ariz) was the only Food & Drug Administration
(FDA)-approved thoracic stent graft for treatment of DTA.
We examined patients treated with the TAG device as well
as the open surgery cohort for the Phase II TAG clinical
trial to determine if there were demographic or intraoper-
ative factors that could predict the primary endpoint of
death within 30 days. Other endpoints included the com-
bined outcomes of death, paraplegia, stroke, or myocardial
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1114infarction. We also sought to determine predictors of vas-
cular complications and of long-term graft-related events
such as migration, endoleak, or conversion. All analyses of
immediate and long-term complications and possible pre-
dictors of major adverse events (MAEs) are new to this
work. Similarly, this is the first work to examine graft-
related complications in a large population of open and
endovascular patients to try to determine predictors of late
interventions so that this information could be used in
patient selection.
METHODS
The Gore TAG pivotal trial was a multicenter, prospec-
tive, non-randomized Phase II study that recruited surgical
candidates with DTA from September 1999 through May
2001. Treatment modality (open or endovascular) was
determined by the surgeon based on patient characteristics
and availability of endovascular grafts. One hundred forty
endovascular patients were enrolled. Ninety-four patients
with DTA treated by open surgery were used as a control
group. Of the 94 open surgical control patients, 44 were
concurrent subjects and 50 were historic controls from the
enrolling institutions. Details on the two populations have
been previously published.8,9 Briefly, patients with DTA of
at least twice the diameter of the normal thoracic aorta and
with 2 cm of non-aneurysmal neck for sealing distal to the
left carotid artery and proximal to the celiac artery were
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from 26 to 40 mm in diameter. All devices in this analysis
were the original TAG endograft available prior to the
revision which eliminated the longitudinal spine and re-
placed the fabric with a low-porosity material. Open repair
was performed according to local protocols at the partici-
pating institutions. The extent of the open repair could not
extend more proximally than the left carotid artery or more
distally than the celiac axis. There were no mandates re-
garding use of spinal cord protection or use of left heart
bypass. High-risk patients, including those with dissection,
rupture, mycotic aneurysm, or trauma were excluded, as
were medically high risk patients.8,9 Follow-up exams,
4-view chest x-rays and spiral CT scans were performed at
1, 6, and 12 months and yearly thereafter. These exams
were performed at 3 months if an endoleak was present.
Five-year follow-ups were concluded for all available pa-
tients in August of 2006.
The 5-year results of the Gore TAG pivotal trial were
analyzed for predictors of morbidity and mortality. Preop-
erative demographic and anatomic characteristics were
used as independent variables to predict intraoperative
results, postoperative complications and long-term out-
comes. Univariate (UVA) and multivariate analyses (MVA)
were conducted to discover possible predictors of major
adverse events. Major adverse events (MAEs) as defined per
Sacks criteria,10 were reported by the study sites and veri-
fied by clinical events coordinators. MAEs were those that
resulted in a prolongation of treatment, new hospitaliza-
tion, major disability, or death. Major and minor adverse
events were adjudicated by a clinical events committee.
Perioperative deaths were those deaths which occurred in
the hospital or within 30 days of the initial procedure. Pre
and postoperative DTAmeasurements and endoleak assess-
ments were performed at the study sites. Significant sac size
change was defined as 5 mm change of the largest diam-
eter of the aneurysm from the baseline 1-month measure-
ment. Migration was defined as a graft shift of 10 mm
either cranial or caudal compared to the 1-month baseline.
Spine fractures, seen in 20 patients in the original TAG
study group prior to the revision of the product, were not
counted as material or device failures in this analysis due to
the acknowledged problem with the product causing the
fractures rather than with patient characteristics as a caus-
ative agent. Endoleaks were infrequently seen with spinal
fractures9,11 and, therefore, were counted as late graft-
related events.
Due to a low frequency of events, the most serious
complications of TEVAR and open DTA repair were com-
bined for an endpoint of death, myocardial infarction (MI),
stroke, or paraplegia. These events were also examined
separately. Patients were analyzed by treatment group and
as an entire cohort for predictors of major adverse events.
All variables with a P value of .10 or lower in univar-
iate analysis were included in multivariate analyses. Mul-
tivariate analysismodelingwas assessedusing theHosmer-
Lemeshow test for goodness of fit. Early adverse outcomes
occurred within 30 days or during the initial hospitaliza-tion. Predictors of late device-related events at 5 years were
analyzed for the TAG group only. A P value of  .05 was
considered significant. Table I lists variables used as predic-
tors of adverse events.
RESULTS
A total of 140 TAG patients (60 women, 80 men) and
94 open patients (46 women, 48 men) were analyzed.
Details of demographic comparisons between the popula-
tions have been previously published.8 The only significant
differences in the preoperative characteristics or presenta-
tions of the patients was that there were significantly more
symptomatic aneurysms in the open surgical group (36/94
[38%] vs 30/140 [21%], P  .007). The designation of
“symptomatic” was made by the treating surgeon without
standardized criteria for this status. The percentage of
patients with a history of coronary artery disease in the TAG
group was slightly higher (49% TAG vs 36% open) and this
trended toward significant (P  .06). With these excep-
tions, there were no other notable preoperative differences.
Mortality. Perioperative deaths were 3/140 (2.1%)
for TAG patients and 9/94 (9.6%) for open procedures
(P .01 in univariate analysis). Details on the perioperative
deaths have been previously reported.8,9,11 The three TAG
deaths were from stroke, cardiac arrest, and sepsis. The 9
Table I. Variables used as predictors of adverse events
including death
Variable
Treatment group (TAG vs open surgical controls)
Age (years)
Race (White vs other)
Gender
Height (cm)
Weight (kg)
History of coronary artery disease (yes/no)
History of angina (yes/no)
History of myocardial infarction (yes/no)
History of cardiac arrhythmia (yes/no)
History of congestive heart failure (yes/no)
History of stroke (yes/no)
History of peripheral arterial occlusive disease (yes/no)
History of vascular intervention (yes/no)
History of arterial and/or venous thromboembolic event (yes/no)
Symptomatic aneurysm (yes/no)
Smoking history (yes/no)
ASA Class (I–IV)
Creatinine value (mg/dL)
Preoperative hematocrit value (%)
Significant patent intercostal arteries (yes/no)
Maximum proximal aortic diameter (mm)
Maximum distal aortic diameter (mm)
Aneurysm diameter (mm)
Proximal aortic neck length (cm)
Aneurysm length (cm)
Distal aortic neck length (cm)
Right and left common iliac diameter (mm)
Right and left external iliac diameter (mm)
Procedural blood loss (mL)open repair deaths were due to respiratory failure (n  4),
ltivaria
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fistula (n  1). Ten of 12 deaths were in men (7 open, 3
TAG) and two were in women (both open surgery DTA
repairs). Patients who were categorized as presenting with a
symptomatic aneurysm had a 12% death rate (8/66) vs a 2%
death rate (4/168) in non-symptomatic patients (P .004
in univariate analysis). The results of the univariate analysis
for predictors of death in the full TAG/open surgery
cohort are presented in Table II. Even though procedure
time was initially found to be significantly associated with
death, this was not included in the multivariate analysis as it
was thought to be a marker for difficult surgery rather than
a causative agent for morbidity or mortality. Additionally, it
was also strongly associated with the type of repair, with
open surgery having predictably longer operating times.
The multivariate analysis for predictors of death in the
entire cohort showed only symptomatic aneurysms (P 
.004) and male gender (P  .048) were significant.
Morbidity. A composite endpoint of death/stroke/
MI/paraplegia was constructed to try to predict the factors
causing the most serious adverse outcomes. Of 17 patients
who suffered spinal cord ischemia, 6 died, all in the open
surgery cohort. Table III shows the incidence of these
events for the entire cohort and by treatment group. Vari-
ables were screened in univariate analysis for both the group
as a whole and for the treatment groups separately. The
Table II. Univariate analysis of predictors of death for op
Variable n P valu
Hx symptomatic aneurysm 234 .004
Treatment group 234 .012
Creatinine value 203 .013
Male gender 234 .031
Increasing height 233 .045
Increasing aneurysm diameter 224 .077
Increasing weight 233 .088
Left external iliac diameter 144 .133
Max proximal neck diameter 181 .192
Hx embolic event 234 .231
Hx vascular intervention 234 .256
Hematocrit 204 .259
Hx PAD 234 .282
Right common iliac diameter 155 .297
Left common iliac diameter 154 .328
Right external iliac diameter 144 .361
Max distal aortic diameter 179 .366
Distal neck length 162 .397
Hx arrhythmia 234 .407
Hx CHF 234 .417
ASA Class 234 .425
Hx stroke 234 .450
Age 234 .517
Hx CAD 234 .669
Hx angina 234 .677
Hx MI 234 .699
Aneurysm length 173 .717
Proximal aortic neck length 166 .842
Max, maximum; Hx, history; CI, confidence interval; PAD, peripheral art
myocardial infarction; ASA, American Society of Anesthesiology.
Shaded variables did not meet the P  .1 threshold for inclusion in the muresults of the univariate analysis are shown in Table IV. Themultivariate model was run using the listed variables as well
as including a variable for treatment group (P  .006 in
univariate analysis for entire cohort). On MVA, only ele-
vated creatinine (P  .002) and treatment group (P 
.006) predicted combined morbidity endpoint in the entire
cohort of DTA repair patients. The predictive value of
elevated creatinine is of questionable validity in the open
surgery group as many of the historic controls did not have
a preoperative creatinine value available. Mean creatinine in
TAG patients with the composite endpoint was 1.54
mg/dL vs 1.06 mg/dL in patients without the composite
endpoint. For open surgery patients this difference was less
pronounced at 1.18 mg/dL with the composite endpoint
d endovascular DTA repair (n  234)
Odds ratio Lower CI Upper CI
0.177 0.046 0.583
4.835 1.398 22.247
6.809 1.546 31.073
0.227 0.034 0.886
1.061 1.001 1.131
1.037 0.996 1.078
1.028 0.996 1.061
1.459 0.891 2.380
1.075 0.961 1.184
0.337 0.078 2.325
2.0 0.611 7.668
0.924 0.807 1.061
0.451 0.126 2.118
0.854 0.618 1.101
0.840 0.532 1.084
1.182 0.793 1.587
1.065 0.928 1.204
0.926 0.728 1.086
1.852 0.471 12.273
0.495 0.119 3.365
1.468 0.588 4.051
0.522 0.127 3.544
1.020 0.964 1.095
0.776 0.236 2.551
1.523 0.279 28.379
0.763 0.217 3.541
1.024 0.888 1.155
0.980 0.763 1.157
isease; CHF, congestive heart failure; CAD, coronary artery disease; MI,
ble model.
Table III. Incidence of death/stroke/MI or paraplegia
TAG
(n  140)
Open control
(n  94)
Total
(n  234)
Composite 11 (7.9%) 17 (18.1%) 28 (12%)
Death 3 (2%) 9 (10%) 12 (5%)
Stroke 5 (4%) 4 (4%) 9 (4%)
MI 1 (0.7%) 1 (1.1%) 2 (0.9%)
Paraplegia 4 (3%) 13 (14%) 17 (7%)
MI, Myocardial infarction.
Note: Patients may have had more than one complication.en an
e
erial dand 1.09 mg/dL without. Treatment group appears to be
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of myocardial infarction and stroke as separate events did
not yield significant predictors, partially due to the low
frequency of these events.
Analysis of paraplegia alone showed that in univariate
analysis, treatment group (P  .002), preoperative hemat-
ocrit value (P  .060) history of arrhythmia (P  .059),
and presence of patent intercostal arteries (P  .091) were
significant. In multivariate analysis, only treatment group
was significant (P  .002). Univariate analysis of the indi-
vidual groups failed to show any significant predictors of
paraplegia to the 0.05 level in the surgical control group. In
the TAG group, decreasing weight was predictive of para-
plegia/paresis (P  .013), but with so few patient affected
(n  4), this finding should be interpreted with caution.
An analysis of predictors of anyMAEwas conducted for
both TAG and open surgery groups. Perioperatively, 28%
of TAG and 70% of open DTA patients had at least one
MAE (P  .001).11 At 5 years, there was still a significant
difference in the occurrence of MAEs, with 57.9% of TAG
and 78.7% of open patients having an MAE at any point
(log rank  .001).11 In the open group UVA, increasing
aneurysm diameter was found to predict any adverse event
(P .02). For TAG patients, a low preoperative hematocrit
value predictedMAEs (P .03), with increasing creatinine
value (P  .057) and increasing aneurysm diameter (P 
.082) trending toward significant. In MVA, using the en-
tire cohort, open surgery treatment group (P  .001) and
increasing aneurysm diameter (P  .001) predicted a sig-
nificantly increased incidence of any major adverse event.
When asymptomatic aneurysm patients were analyzed
as a separate cohort, univariate analysis in the open surgery
group showed a history of smoking predicted any MAE.
Multivariate analysis demonstrated a high creatinine value
(P  .005) and short proximal neck length (P  .009)
predicted events in the endovascular group. Multivariate
analysis for all non-symptomatic DTA patients was signifi-
cant for treatment group (open surgery predicting any
MAE) (P .01). Meaningful analysis of the asymptomatic
group for risk factors for death was not performed due to
the low incidence of this event.
Vascular complications of intraoperative hemorrhage,
thrombosis, or acute ischemia were seen in 19% of TAG
patients and 9% of open surgical patients (P  .038). Male
Table IV. Significant predictors of the composite endpoin
univariate analysis, separated by treatment group
Variable n
TAG Increasing creatinine value 139
n  140 History of angina 140
Proximal aortic neck length 136
Open Surgery Increasing height 94
n  94 History of smoking 94
Increasing age 94
CI, Confidence interval.patients had a 10% risk of perioperative vascular events(13/128) vs a 20% rate in women (21/106) (P  .01).
Results of the univariate analysis demonstrated that de-
creasing weight (P  .007), endovascular treatment (P 
.027), decreasing iliac diameter (P  .034), female gender
(P  .037), increasing age (P .038), and symptomatic
aneurysms (P  .046) were all predictors of vascular com-
plications. However, when put into a multivariate analysis,
missing data from the open control group (iliac diameters)
prevented a reliable model from being constructed for the
entire cohort. Within the TAG treatment group only, gen-
der (P  .01) was found to predict vascular complications.
Age, body-mass index (BMI), iliac diameter, and symptom-
atic aneurysm were not found to have a predictive value.
Longer procedure times were again found to be correlated
with adverse events. TAG procedure times were signifi-
cantly longer for women at a mean of 180 minutes (range,
65-580) vs 129 minutes (range, 61-290) for men (P 
.001).
Graft-related events. Graft-related events at 5 years
were examined and analyzed for predictive factors. Table V
lists these events from the operative period through long-
term follow-up. The operative events have been previously
described.9 The number of patients with an endoleak at any
time was 10%, and at 5 years of follow-up 4.3% of patients
had an active endoleak. A detailed description of the en-
doleaks, treatment, and all graft-related events in follow-up
has been released.11 In brief, 3 patients have undergone
death/stroke/MI/paraplegia by treatment group in
P value Odds ratio Lower CI Upper CI
.001 11.38 2.77 60.54
.052 0.25 0.07 1.01
.064 0.83 0.63 1.01
.024 1.06 1.01 1.11
.056 0.19 0.01 1.04
.070 1.05 0.10 1.13
Table V. Graft-related events at 5 years
Event 30 (21%)**
Branch vessel occlusion* 4 (3%)
Deployment failure* 1 (1%)
Lumen obstruction* 1 (1%)
Device complication at treatment* 4 (3%)
Endoleak (total number of patients with endoleak
at any time) 15 (10.6%)
Increase in diameter 5 mm 8 (19%)
Prosthesis migration 1 (1%)
Prosthesis material failure 1 (1%)
Extrusion/erosion 0 (0%)
Aneurysm rupture 0 (0%)
Other complication at follow-up 2 (1.4%)
*Intraoperative event at initial procedure.
**Patients may have had more than 1 event.t ofadditional extension procedures for endoleak. Nineteen
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ment at 5 years of follow-up, and no interventions have
been performed for this. One instance of proximal migra-
tion was noted and was most likely due to a poor seal at the
original procedure. This patient underwent successful con-
version. Two additional complications during follow-up
were infections due to aorto-esophageal fistula. Both of
these patients died as a result of this condition. Analysis of
the TAG cohort failed to demonstrate any predictive vari-
able for these events, or for graft events in general.
DISCUSSION
This is the first attempt to define predictors of morbid-
ity and mortality in a combined open and endovascularly
treated population of patients treated for descending tho-
racic aneurysms. We found that symptomatic aneurysms
and male gender predicted death in the entire cohort of
DTA repair patients. Although the multivariate analysis did
not demonstrate a treatment group effect for mortality, this
was thought to be related to a confounding effect of
symptomatic aneurysms. The negative predictive effect of
symptomatic aneurysms is not difficult to understand, even
though none of these patients were thought to have an
acute rupture. The lack of patient optimization in urgent
surgery coupled with the potential hemodynamic instability
and inflammatory cascade involved in an acute presentation
is known to translate into worse outcomes.12,13 The fact
that significantly more symptomatic aneurysms were found
in the open treatment group does have a confounding
effect with the treatment group. In univariate analysis,
symptomatic aneurysms (P  .004) and open repair (P 
.01) both predicted death. When constructing the multi-
variate model, symptomatic aneurysms had more weight
due to the lower P value, and this, in part, negated the
effect of treatment group. The strong predictive effect of
male gender, however, is more surprising. There is ample
literature describing worse outcomes after infrarenal ab-
dominal aortic aneurysm (AAA) repairs in women vs
men,14-19 and women were noted in our series to have
longer procedure times and a higher incidence of vascular
complications. We attribute both the longer procedure
times and the higher number of vascular complications to
smaller iliac arteries found in women. Although there was
an association with longer procedure times and all compli-
cations, this did not translate into increased mortality in
women.
The predictor of serious morbidity in the entire cohort
was found to be an elevated creatinine level, although no
patients were in renal failure. There is strong evidence that
even subtle elevations in creatinine can translate into ad-
verse perioperative events.20,21 However, this finding is
more meaningful in the TAG group as data for the open
surgical patients did not always include creatinine values.
We interpret these results to indicate that in patients with
even subtle elevations in creatinine renal dysfunction may
be a marker for systemic vasculopathy and that these pa-
tients should be warned that they may have a higher inci-
dence of complications. Although procedure time wasfound to have a significant predictive effect for many ad-
verse events, the authors determined that this was a marker
for difficult surgery rather than a risk factor in and of itself.
Additionally, long procedure times were strongly corre-
lated with open surgery and would have altered compari-
sons within the entire DTA cohort, falsely biasing analyses
in favor of the TAG group.
Open surgery and larger aneurysms were found to
predict the occurrence of any adverse event in follow-up,
and open surgery was the only reliable predictor of paraple-
gia in the entire DTA cohort. These associations are not
surprising, but do lend weight to the argument in favor of
TEVAR. This is especially compelling in that adverse
events, including endoleaks, and sac enlargements were
tabulated out to 5 years. The finding that even with late
graft-related events there are significantly fewer MAEs with
endovascular DTA repair illustrates that this is a durable
procedure and less morbid than open surgery in appropri-
ate patients. Unfortunately, no reliable predictors could be
determined for late graft-related events.
The strengths of this study are that data was prospec-
tively collected, and all complications have been verified by
independent practitioners and a clinical events committee.
There are a relatively large number of patients involved,
although even with 234 patients we were unable to perform
many important analyses due to the low number of index
events or missing data points. Missing data points were
primarily seen in the open surgical patients, especially his-
toric controls. These restrictions lead to the formation of
the composite morbidity point in order to be able to predict
themost serious perioperative events, as each separate event
happened too infrequently.
Unfortunately, this population was not randomized to
open vs endovascular repair – a study that will most likely
never be completed. We know that there were more symp-
tomatic aneurysm patients in the open repair group, and
this fact had a profound effect on the overall conclusions of
our analysis due to the high death rate within this popula-
tion. Although there was marginally more cardiac disease
within the TAG group, we did not see significant differ-
ences in postoperative cardiac events between the 2 groups.
CONCLUSION
Morbidity and mortality within the TAG and open
surgery cohorts were low for DTA repair. Symptomatic
aneurysms and male gender were found to predict death
overall, and both of these variables were found more often
in the open surgery group. There was increased morbidity
associated with an elevated creatinine for the entire cohort.
Vascular complications were seen more often in women
and with endovascular repair. Open surgery predicted any
major adverse event and paraplegia.
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Dr Jeffrey P. Carpenter (Philadelphia, Pa). Drs Dillavou and
Makaroun have enlarged our understanding of thoracic aortic repair
by identifying some preoperative risk factors for morbidity and mor-
tality after both open and TEVAR [thoracic endovascular aneurysm
repair] approaches using the TAG [W. L. Gore and Associates,
Flagstaff, Ariz] database. They have identified a number of risk factors,
which unfortunately cannot be modified, that predict bad outcomes:
gender, height, renal function, presentation, and age, among those.
I would ask, therefore, what is our take-homemessage regard-
ing patient selection for open or endovascular repair from these
data? Howwould you reduce these findings to actual practice? Can
you tell us a little more about the endoleak rate of 10.6%? Are these
mostly type II leaks, or are they attachment or junction leaks? Also,
could you comment on that sac expansion rate of 19%. Is that
endotension as we saw with the abdominal excluder, or is this a
different problem with the TAG? What have your investigators
done about that issue, and what is recommended?
Also, I am fascinated by your finding in the manuscript, which
you provided to me, that the short proximal neck length predicted
perioperative morbidity. Perhaps that is a modifiable risk factor.
What are the practical implications of this short neck finding
related to morbidity?
And then, finally, in light of the finding of prospective ran-cular means, specifically that there is no long-term mortality ben-
efit to EVARwhen compared with open aneurysm repair. Payment
has been denied for EVAR in parts of Europe. EVAR is under very
careful scrutiny by payers in this country as well.
Now, I know the TAG database is not a randomized study of
open vs endovascular repair of thoracic aneurysms, but it remains
the best available data set we have for comparison between open
and endovascular groups. Do you have any glimpse of the long-
term comparison of mortality between those groups? Does the
mortality benefit in the perioperative period that you noted extend
to the longer term?
Dr Dillavou. Thank you, Dr Carpenter. Going through the
questions one by one, you ask an excellent question about what is
the take-home message from these data. I agree that some factors
cannot be changed. However, I believe that we can use this
information to educate patients and to enhance patient selection.
Some proactive measures can also be taken. For instance, if we
know that women have a higher chance of vascular complications
after TAG endografting, perhaps planning a conduit is the better
choice rather than just deciding to forge through.
You ask about the endoleak rate of 10.6% at 5 years.We found that
most of thesewere attachment site leaks, and theywere fixed relatively
easily over time. Only three patients have had to undergo conversion,
two were for aortoenteric fistulas and one was for proximal migration
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for endoleaks. All were able to be treated percutaneously.
The sac expansion rate of 19% at 5 years is something that
deserves attention. A few patients had endoleaks, but the vast
majority of them did not. We attribute sac expansion to the same
forces and porosity that we see in the abdominal group. All of these
TAG grafts that were put in were the standard expanded PTFE
[polytetrafluoroethylene] grafts.
Comparing these grafts to the low-porosity TAGs showed
differences that did not achieve statistical significance; at 2 years in
the low-porosity group, we saw a 3% sac expansion vs a 13% sac
expansion in the regular group. We hope that the low-porosity
graft will decrease sac expansion. Thus far, no action has been taken
on these patients if no endoleak is found.
You ask about short proximal neck length related to perioperative
morbidity. We have found that with carotid–subclavian bypass, there
is a statistically higher incidence of stroke after endografting. This is
true whether or not the carotid–subclavian bypass was done preoper-
atively or immediately postoperatively.Wehypothesize that this is due
to a more diseased arch and more manipulation. All strokes were
perioperative events. This is something to take into consideration
when planning the operation and educating the patient.
Finally, you ask about our results and compared them to the
EVAR I and II trials done in the United Kingdom. We found that
there was a significant aneurysm-related survival difference, with a
higher aneurysm-related survival in the thoracic endograft group
compared to the open surgical group. However, looking at overall
mortality, there was no difference between the groups at 5 years. So
there is a difference in aneurysm mortality, and it persists to 5 years.
Dr Keith D. Calligaro (Philadelphia, Pa). Dr Dillavou, very
nice presentation. I know this was retrospective and you can’t really
match up the patients. The question is whether patients who
underwent open surgical repair did so because they did not have an
adequate neck proximal or distal? If there wasn’t an adequate
landing zone for an endograft, more of the patients undergoing
open repair might require clamping above the subclavian or below
the viscerals and that alone would increase the morbidity.
Dr Dillavou. No. The clamp site limits were basically the same
for both groups, that the proximal clamp could not have been placed
more proximal then the left carotid artery and the distal clamp could
not be placed more distally than the celiac trunk. So the clamp sites
were the same. Some of these were historic controls that were done
prior to the availability of the endovascular graft.
DrMaciej L. Dryjski (Buffalo, NY). I have a question regarding
the mortality. How would you explain the higher mortality in the
symptomatic group of patients? Is it perhaps that the symptoms were
not related to the aneurysm itself, but rather some other medical
condition?Dr Dillavou. To make sure I understand your question, you
are asking if I believe that the increased mortality in the symptom-
atic aneurysm group was because of hemodynamic instability and
presentation?
Dr Dryjski. Were these patients hemodynamically unstable,
or were the symptoms related to some other condition, not neces-
sarily an expanding aneurysm?
Dr Dillavou. These were not hemodynamically unstable pa-
tients. There was no one with a rupture or a leak or anything like
that. These were patients who presented, whom the surgeon felt
were having pain or other symptoms due to the aneurysm, and in
most cases they were done more urgently than a traditional
planned aneurysm repair. It is my hypothesis that part of the reason
that these patients have an increased mortality is because that their
operations probably were less electively planned. We did not find
any difference in operating room blood loss or other intraoperative
factors, hematocrit values, things like that.
Procedure times were slightly longer for symptomatic vs non-
symptomatic aneurysms, but there again, that just may be related
to the more difficult nature of the anatomy. There is no concrete
reason why the symptomatic aneurysm group had such a dramatic
increase in mortality, but my hypothesis is just that the patients
were not optimized prior to their repairs. Also, some of these
patients may not have been offered elective surgery due to ana-
tomic or medical factors, but because they presented symptomat-
ically they underwent a repair.
Dr Marat Goldenberg (Reading, Pa). I have a two-part
question. You said that in women the operative time was longer.
Question number 1, do you think this is due to the smaller access
vessels or unique characteristics of the aneurysm? Do you think
they have higher level of complication because of the longer time
under anesthesia or the degree of difficulty?
Dr Dillavou. That’s an excellent question. I believe that the
longer procedure times were probably related to smaller access
vessels and also to complications that were encountered in the
operating room. More than half of the vascular complications that
we saw were actually dealt with at the time of the procedure—iliac
artery ruptures, femoral artery occlusions, et cetera—and so this
obviously adds to procedure time. It is my belief that this, the
difficult access, is the cause and the long procedure time is the
effect, although it is impossible to know for sure.
That is something that we struggled with statistically in this
database, and that is that long procedure times, no matter what we
were analyzing, long procedure times predicted bad outcomes. But
we also saw predictably longer procedure times with open surgery
and in patients with complications, which all sort of goes together.
And so it is my hypothesis that the long procedure times were an
effect rather than the cause of the morbidities.
